Tandem Diabetes Care | TNDM - Ebitda



金融业
股票价格
USD
资产
USD 881.11M
现金及等价物
USD 90.63M
销售成本
USD 122.92M
流动资产
USD 618.14M
流动负债
USD 242.72M
债务
USD 449.28M
EBIT
USD 8.29M
EBITDA
USD 32.9M
员工
2.65K
EPS每股收益
USD -0.01
股本和储备
USD 155.17M
销售毛利
USD 167.46M
债务利息支出
USD 2.08M
利息收入
USD 2.51M
贷款资金
USD 310.04M
市值
USD 1.57B
净收入
USD -589K
营业费用
USD 282.09M
营业利润
USD 8.29M
普通股股本
USD 68.29M
PE价格收益
681.05
税前利润
USD -25.14M
销售收入
USD 290.4M
销售和管理费用
USD 99.86M
股票
USD 128.77M
贸易债权人
USD 47.07M
应收帐款人
USD 165.49M


Ebitda 更改 日
Abbott USD 3.09B 44M 2025-09
Accuray USD -685K 900K 2024-09
Align Technology USD 183.84M 19.77M 2025-09
AtriCure USD 19.86M 2.06M 2025-12
Baxter International USD 426M 36M 2025-09
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.37B 1000K 2025-09
Cooper Companies USD 323.4M 13.2M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 464.3M 4.7M 2025-09
Eli Lilly USD 7.88B 378.1M 2025-09
Globus Medical USD 280.46M 27.86M 2025-12
ICU Medical USD 98.19M 27.67M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 919.7M 21M 2025-09
J&J USD 9.52B 389M 2025-09
Masimo USD 91.9M 19.9M 2025-09
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Orthofix International USD 27.88M 2.77M 2025-12
Roche Holding CHF 12.68B 2.36B 2024-06
Stryker USD 1.67B 206M 2025-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Zimmer Biomet Holdings USD 759M 120.8M 2025-12